Photochemical identification of the binding region for (S)-semotiadil on sodium channels: Comparison with that for (R)-semotiadil on skeletal muscle calcium channel

Heterocycles

Volumn 59, Issue 2, 2003, Pages 613-622

  Yoshikawa, Hiromi ^a   Shimizu, Eisuke ^a   Kawahara, Kohichi ^a   Kuniyasu, Akihiko ^a   Shibano, Toshiro ^b   Nakayama, Hitoshi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b DAIICHI SANKYO CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; D 51 4700; POLYCLONAL ANTIBODY; PROTEINASE; SESAMODIL FUMARATE; SODIUM CHANNEL BLOCKING AGENT; TRITIUM; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; BRAIN SYNAPTOSOME; CALCIUM CHANNEL; CONTROLLED STUDY; DRUG BINDING SITE; ENANTIOMER; HEART MUSCLE FIBER MEMBRANE; IMMUNOPRECIPITATION; NONHUMAN; PHOTOAFFINITY LABELING; POLYACRYLAMIDE GEL ELECTROPHORESIS; RAT; SKELETAL MUSCLE; SODIUM CHANNEL; SWINE;

EID: 0037346149     PISSN: 03855414     EISSN: None     Source Type: Journal    
DOI: 10.3987/com-02-s62     Document Type: Article

References (30)

1. N. Miyawaki, F. Yamazaki, T. Furuta, T. Shigei, and H. Yamauchi, Drug. Dev. Res., 1991, 22, 293.
2. I. Kodama, R. Suzuki, K. Maruyama, and J. Toyama, Br. J. Pharmacol., 1995, 114, 503.
3. A. Hirasawa, A. Haruno, T. Matsuzaki, and K. Hashimoto, Jpn. Heart J., 1992, 33, 851.
4. S. Nagashima, T. Uematsu, T. Araki, M. Matsuzaki, H. Fukuchi, and M. Nakashima, Naunyn-Scmided. Arch. Pharmacol., 1992, 345, 688.
5. Y. Hatanaka, H. Nakayama, and Y. Kanaoka, Rev. Heteroatom Chem., 1996, 14, 213.
6. A. Kuniyasu, K. Itagaki, T. Shibano, M. Iino, G. Kraft, A. Schwartz, and H. Nakayama, J. Biol. Chem., 1998, 273, 4635.
7. N. Ii, A. Kuniyasu, K. Kawahara, T. Shibano, A. Schwartz, and H. Nakayama, FEBS Lett., 1998, 441, 83.
8. H. Nakayama, M. Taki, J. Striessnig, H. Glossmann, W. A. Caterall, and Y. Kanaoka, Proc. Natl. Acad. Sci. USA., 1991, 88, 9203.
9. J. Striessnig, H. Glossmann, and W.A. Catterall, Proc. Natl. Acad. Sci. USA., 1990, 87, 9108.
10. W.A. Catterall and J. Striessnig, Trends Pharmacol. Sci., 1992, 13, 256.
11. G. Varadi, Y. Mori, G. Mikala, and A. Schwartz, Trends Pharmacol. Sci., 1995, 16, 43.
12. W. A. Catterall, Ann. Rev. Cell Dev. Biol., 2000, 16, 521.
13. H. Glossmann and J. Striessnig, Rev. Physiol. Biochem. Pharmacol., 1990, 114, 1.
14. H. Nakayama and Y. Kanaoka, Heterocycles, 1996, 42, 901.
15. H. K. Motoike, I. Bodi, H. Nakayama, A. Schwartz, and G. Varadi, J. Biol. Chem., 1999, 274, 9409.
16. M. Noda, S. Shimizu, T. Tanabe, T. Takai, T. Kayano, T. Ikeda, H. Takahashi, H. Nakayama, Y. Kanaoka, N. Minamino, K. Kangawa, H. Matsuo, M. A. Raftery, T. Hirose, S. Inayama, H. Hayashida, T. Miyata, and S. Numa, Nature, 1982, 312, 121.
17. H. Nakayama, Y. Hatanaka, E. Yoshida, K. Oka, M. Takanohashi, Y. Amano, and Y. Kanaoka, Biochem. Biophys. Res. Commun., 1992, 184, 900.
18. A. Lombet and M. Lazdunski, Eur. J. Biochem., 1984, 141, 651.
19. A. L. Goldin, Curr. Opin. Neurobiol., 1993, 3, 272.
20. W. A. Catterall, Science, 1991, 253, 1499.
21. C. Sato, Y. Ueno, K. Asai, K. Takahashi, M. Sato, A. Engel, and Y. Fujiyoshi, Nature, 2001, 409, 1047.
22. K. Murata, N Odahara, A. Kuniyasu, Y. Sato, H. Nakayama, and K. Nagayama, Biochem. Biophys. Res. Commun., 2001, 282, 284.
23. Y. Watanabe, K. Osanai, T. Nishi, N. Miyawaki, D. Shii, T. Honda, and T. Shibano, Bioorg. Med. Chem. Lett., 1996, 6, 1923.
24. M. Noda T. Ikeda, T. Kayano, H. Suzuki, H. Takeshima, M. Kurasaki, H. Takahashi, and S. Numa, Nature, 1986, 320, 188.
25. T. Ueda, P. Greengard, Berzins, R. S. Cohen, F. Blomberg, D. J. Grab, and P. Siekevitz, J. Cell Biol., 1979, 83, 308.
26. R. P. Hartshone and W. A. Catterall, Proc. Natl. Acad. Sci. USA., 1981, 78, 4620.
27. A. Kuniyasu, K. Oka, T. Ide-Yamada, Y. Hatanaka, T. Abe, H. Nakayama, and Y. Kanaoka, J. Biochem., 1992, 112, 235.
28. D. S. Ragsdale, J. C. Mcphee, T. Scheuer, and W. A. Catterall, Science, 1994, 265, 1724.
29. U. T. Laemmli, Nature, 1970, 227, 680.
30. W. Voigt and R. Mannhold, Eur. J. Pharmacol., 1989, 169, 103.